VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH / TSX:AUP) today announced that its President and CEO Stephen Zaruby will attend and discuss the corporate overview of the company at the Canaccord Genuity Rare Disease and Bio-Pharma One on One Day, taking place February 2nd, 2016 in New York at the Omni Berkshire Place Hotel.
